LAN; Nancy C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for LAN; Nancy C..The latest application filed is for "substituted 2-aminoacetamides and the use thereof".

Company Profile

0.23.16

LAN; Nancy C. - South Pasadena CA
Lan; Nancy C - Pasadena CA
LAN; Nancy C. - Altadena CA
Lan; Nancy C - Altadena CA
Lan, Nancy C. - Pasadena CA
Lan; Nancy C. - S. Pasadena CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted 2-Aminoacetamides and the Use Thereof App 20130303568 - LAN; Nancy C. ; et al.	2013-11-14
Substituted 2-aminoacetamides and the use thereof Grant 8,426,431 - Lan , et al. April 23, 2	2013-04-23
Substituted 2-Aminoacetamides and the Use Thereof App 20110269785 - Lan; Nancy C. ; et al.	2011-11-03
Substituted 2-aminoacetamides and the use thereof Grant 7,872,127 - Lan , et al. January 18, 2	2011-01-18
Substituted 1(2H)-phthalazinones and pharmaceutical compositions thereof Grant 7,652,006 - Upasani , et al. January 26, 2	2010-01-26
Substituted 2-Aminoacetamides and the Use Thereof App 20090240053 - Lan; Nancy C. ; et al.	2009-09-24
Sodium Channel Blocker Compositions and the Use Thereof App 20080318932 - LAN; Nancy C.	2008-12-25
Sodium channel blocker compositions and the use thereof Grant 7,393,872 - Lan July 1, 2	2008-07-01
Substituted 2-aminoacetamides and the use thereof App 20060217403 - Lan; Nancy C. ; et al.	2006-09-28
Substituted 2-aminoacetamides and the use thereof Grant 7,091,210 - Lan , et al. August 15, 2	2006-08-15
Substituted 5-oxo-5, 6, 7, 8-tetrahydro-4H-1-benzopyrans Grant 6,800,657 - Konkoy , et al. October 5, 2	2004-10-05
Neuroactive steroids of the androstane and pregnane series Grant 6,780,853 - Upasani , et al. August 24, 2	2004-08-24
Substituted quinazolines and analogs and the use thereof App 20040162299 - Upasani, Ravi ; et al.	2004-08-19
Substituted 5-oxo-5, 6, 7, 8-tetrahydro-4h-1-benzopyrans App 20040097581 - Konkoy, Christopher S. ; et al.	2004-05-20
Sodium channel blocker compositions and the use thereof App 20040054005 - Lan, Nancy C.	2004-03-18
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof Grant 6,696,442 - Wang , et al. February 24, 2	2004-02-24
Substituted 5-oxo-5,6,7,8-tetrahydro-4H-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of AMPA Grant 6,680,332 - Konkoy , et al. January 20, 2	2004-01-20
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof App 20030225080 - Wang, Yan ; et al.	2003-12-04
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof Grant 6,613,803 - Wang , et al. September 2, 2	2003-09-02
Subtype-selective NMDA receptor ligands and the use thereof App 20030144319 - Bigge, Christopher F. ; et al.	2003-07-31
Substituted 2-aminoacetamides and the use thereof App 20030130295 - Lan, Nancy C. ; et al.	2003-07-10
Substituted quinazolines and analogs and the use thereof App 20030033089 - Upasani, Ravi ; et al.	2003-02-13
Substituted 2-aminoacetamides and the use thereof Grant 6,500,825 - Lan , et al. December 31, 2	2002-12-31
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof App 20020183321 - Wang, Yan ; et al.	2002-12-05
Substituted 2-aminoacetamides and the use thereof Grant 6,479,484 - Lan , et al. November 12, 2	2002-11-12
Substituted quinazolines and analogs and use thereof Grant 6,465,472 - Upasani , et al. October 15, 2	2002-10-15
Sodium channel blocker compositions and the use thereof App 20020037926 - Lan, Nancy C.	2002-03-28
Substituted 2-aminoacetamides and the use thereof App 20020016464 - Lan, Nancy C. ; et al.	2002-02-07
Subtype-selective NMDA receptor ligands and the use thereof App 20010051633 - Bigge, Christopher F. ; et al.	2001-12-13
Substituted semicarbazides and the use thereof Grant 6,281,211 - Cai , et al. August 28, 2	2001-08-28
4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists Grant 6,130,234 - Bigge , et al. October 10, 2	2000-10-10
4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists Grant 6,124,323 - Bigge , et al. September 26, 2	2000-09-26
2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists Grant 6,124,317 - Bigge , et al. September 26, 2	2000-09-26
Neuroactive steroids of the androstane and pregnane series Grant 5,925,630 - Upasani , et al. July 20, 1	1999-07-20
Substituted 2,3-benzodiazepin-4-ones and the use thereof Grant 5,891,871 - Xia , et al. April 6, 1	1999-04-06
Method, compositions, and compounds for modulating brain excitability Grant RE35,517 - Gee , et al. May 20, 1	1997-05-20
Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series Grant 5,591,733 - Bolger , et al. * January 7, 1	1997-01-07
Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series Grant 5,232,917 - Bolger , et al. August 3, 1	1993-08-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.